Literature DB >> 1684884

[Incidence of use of various myocardial infarct treatments in 2 Swiss regions].

J M Gothuey1, V Wietlisbach, M Rickenbach, F Barazzoni, C la Vecchia.   

Abstract

Two regions in Switzerland (Vaud-Fribourg and Ticino) participate in the WHO MONICA project (MONItoring of trends and determinants in CArdiovascular disease). Within this context, all hospitalizations of men for ischemic heart disease will be recorded during a period of ten years. All cases are classified according to uniform criteria, in three categories: definite myocardial infarction, possible myocardial infarction or no myocardial infarction. In 1986, the records were completed with a summary of treatments. The treatment of 334 patients with definite myocardial infarction, aged between 25 and 64 years, surviving after 27 days are analyzed (VD-FR: 217; TI: 117). Results show that anticoagulants were administered in a routine fashion (in 97% of the cases), whilst thrombolysis, applied in 1986 by only one hospital in each area, concerned only 9% of the patients. As compared to Ticino, VD-FR distinguished itself by its significantly higher use of anti-arrhythmia drugs (69% versus 47%; p less than 0.005), nitrates (97% versus 86%; p less than 0.005) and beta-blockers (57% versus 43%; p less than 0.05). Furthermore, patients from VD-FR spent more time in the intensive care unit (6.4 versus 3.7 days; p less than 0.005) and participated more frequently in rehabilitation programmes (47% versus 12%; p less than 0.005). The discussion compares the observed therapy with results published in the literature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684884     DOI: 10.1007/bf01368741

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  31 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

Review 2.  Calcium channel blockers in patients with both hypertension and angina pectoris.

Authors:  W H Frishman; E J Lazar
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

3.  Switzerland's participation in MONICA.

Authors:  M Rickenbach; F Gutzwiller; V Wietlisbach; J Martin; F H Epstein
Journal:  Soz Praventivmed       Date:  1985

4.  Therapy for myocardial infarction: effect on trends in coronary disease mortality.

Authors:  B Pitt
Journal:  Int J Epidemiol       Date:  1989       Impact factor: 7.196

5.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

Authors: 
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983

Review 6.  Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.

Authors:  S Yusuf; R Collins; S MacMahon; R Peto
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

Review 7.  [The treatment of ischemia in acute myocardial infarction].

Authors:  W Kiowski
Journal:  Schweiz Med Wochenschr       Date:  1990-10-20

8.  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.

Authors: 
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

9.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

10.  A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

Authors: 
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

View more
  1 in total

1.  Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008.

Authors:  Charlène Insam; Fred Paccaud; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.